Skip to main content

JANE STREET GROUP, LLC

Position in GALT — Galectin Therapeutics Inc

CIK 1595888 NEW YORK, NY

Position in GALT

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$543,681
-$285,568 QoQ
Shares Held
194,868
-2.2% QoQ
Ownership
0.296%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Derivatives in GALT

reported options exposure · as of Mar 31, 2026
CallValue
$467,046
CallShares
167,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,255,284,514 across 317 Biotechnology names. GALT ranks #152 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GALT

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $467,046 167,400
2026-03-31 $543,681 194,868
2025-12-31 $750,048 180,300
2025-12-31 $829,249 199,339
2025-09-30 $62,225 14,676
2025-06-30 $1,579,655 748,652
2024-12-31 $115,455 89,500
2024-12-31 $90,429 70,100
2024-03-31 $87,915 36,785
2023-12-31 $56,056 33,769
2023-03-31 $85,096 40,522
2022-12-31 $39,999 35,398
2021-12-31 $87,147 42,100
2021-09-30 $182,748 47,100
2021-06-30 $40,320 12,600
2021-06-30 $35,625 11,133